Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and Commentaries
| |
High plasma concentrations of zidovudine (AZT) do not parallel
intracellular concentrations of AZT-triphosphates in infants during prevention
of mother-to-child HIV-1 transmission.
Kinai E, Kato S, Hosokawa S, Sadatsuki
M,
et al
J Acquir Immune Defic Syndr.
2016 Feb 8
Abstract
Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental
passage of zidovudine.
Neumanova Z, Cerveny L, Ceckova M, Staud F.
Biopharm Drug Dispos. 2015
Sep 21.
Abstract
The changes in bone organic and inorganic matrix in newborn rats
after maternal application of antiretroviral agents: Indinavir and zidovudine.
Maciejewska K, Drzazga
Z, Kaszuba M.
Biofactors. 2015 May
6;41(3):198-208. d
Abstract
Economic Evaluation of 3-Drug Antiretroviral Regimens for the
Prevention of Mother-to-Child HIV Transmission in Thailand.
Werayingyong P, Phanuphak N, Chokephaibulkit K, wt al
Asia Pac J Public Health.
2013 May 30
Abstract
Is Intrapartum Intravenous Zidovudine for Mother-to-Child HIV-1
Transmission Still Useful in the cART Era?
Briand N,
Warszawski J, Mandelbrot L, et al
Clin Infect Dis. 2013 May 31
Abstract
High exposure to zidovudine during the two first weeks of life and concentration
- toxicity relationships.
Hirt D, Warszawski J, Firtion G, Giraud C,
J Acquir Immune Defic Syndr.
2013 Mar 11.
Abstract
FULL-TEXT ARTICLE
Maternal CD4+ Cell Count Decline after Interruption of Antiretroviral
Prophylaxis for the Prevention of
Mother-to-Child Transmission of HIV.
Ekouevi D, Abrams EJ, Schlesinger M,
et al
PLoS One.
2012;7(8):e43750.
Paper
FULL-TEXT ARTICLE
Zidovudine Exposure in HIV-1 Infected Tanzanian Women Increases Mitochondrial
DNA Levels in Placenta and Umbilical Cords.
Kunz A, von Wurmb-Schwark N, Sewangi J,
et al
PLoS One. 2012;7(7):e41637
Paper
Effects of short-course zidovudine on the selection of
nevirapine-resistant HIV-1 in women taking single-dose nevirapine.
Micek MA, Blanco AJ, Carlsson J, et al
J
Infect Dis. 2012 Apr 5.
Abstract
Perinatal zidovudine prophylaxis in HIV type-1-infected pregnant women with
thalassaemia carriage in Thailand.
Briand N, Pornprasert S, Ngo-Giang-Huong N, Galactéros F
Antivir Ther.
2009;14(1):117-22.
Abstract
|
AZT Availability in Illinois Birthing Hospitals: Is the Perinatal HIV
Prevention Safety Net in
Place?
Eary RL, Borders AE, Handler A, et al
Matern Child Health J. 2007 Jan 23
Abstract
|
Determinants of mother-to-infant human
immunodeficiency virus 1 transmission
before and
after the introduction of
zidovudine prophylaxis.
The Italian Register for Human Immunodeficiency Virus Infection in Children
Arch Pediatr Adolesc Med 2002 Sep;156(9):915-2
Abstract
Zidovudine: A Review of its Use in the Management of
Vertically-Acquired Pediatric
HIV infection.
Bhana N,Ormrod D, Perry CM, et al.
Paediatr Drugs 2002;4(8):515-53
Abstract |
|
Conference Reports, Abstracts, and Posters
| |
Maternal and fetal zidovudine pharmacokinetics during
pregnancy and labor: too high dose infused at labor?
Fauchet F, Treluyer JM, Valade
E, et al
Br J
Clin Pharmacol. 2014 Jul 9.
Abstract
Pharmacokinetics of Zidovudine Dosed Twice Daily According to
World Health Organization Weight Bands in Ugandan HIV-infected Children.
Fillekes Q, Kendall L, Kitaka S, Mugyenyi P, et al
Pediatr Infect Dis J. 2014
May;33(5):495-498.A
Abstract
Pharmacokinetics and tolerance of zidovudine in preterm infants.
Capparelli EV, Mirochnick M, Dankner WM,
et al
J Pediatr 2003 Jan;142(1):47-52
Abstract
Pharmacokinetics of zidovudine in infants: a population
analysis across studies.
Mirochnick M, Capparelli E, Connor
J Clin Pharmacol Ther 1999
Jul;66(1):16-24
Abstract |
|
Journal Papers, Abstracts,
and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
| |
Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women
Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine.
Bosire R, Farquhar C, Nduati R,
et al
Pediatr Infect Dis J. 2017 Aug 19.
Abstract
Zidovudine use in pregnancy and congenital malformations: meta-analysis and
Bayesian incorporation of Medicaid data.
Rough K, Sun JW, Seage GR 3rd, et al
AIDS.
2017 May 23.
Zidovudine treatment in HIV-infected pregnant women is associated
with fetal cardiac remodelling.
García-Otero L, López M,
Sitges M, et al
AIDS. 2016 Feb
25.
Abstract
Prenatal exposure to zidovudine and risk for ventricular
septal defects and congenital heart defects: data from the
Antiretroviral Pregnancy Registry.
Vannappagari V, Albano JD, Koram
N,
Eur J Obstet Gynecol Reprod Biol.
2015 Nov 24;197:6-10.
Abstract
Risk factors of preterm delivery in HIV-infected pregnant women receiving
zidovudine for the
prevention of perinatal HIV.
Traisathit P,
Mary JY, Le Coeur S, et al
J Obstet Gynaecol Res.
2009 Apr;35(2):225-33.
Abstract |
Placental transfer of Zidovudine in first trimester of pregnancy.
Siu SS, Yeung JH, Pang MW, et al
Obstet Gynecol. 2005 Oct;106(4):824-7.
Abstract
|
Absence of cardiac toxicity of zidovudine in infants. Pediatric
Pulmonary and Cardiac
Complications of Vertically Transmitted HIV Infection Study Group.
Lipshultz SE, Easley KA, Orav EJ,
et al.
N Engl J Med 2000 Sep 14;343(11):759-66
Abstract |
| |
|
| |
Risk factors for preterm birth, low birth weight, and intrauterine growth
retardation in
infants born to HIV-infected pregnant women receiving zidovudine. Pediatric
AIDS Clinical
Trials Group 185 Team.
Lambert JS, Watts DH, Mofenson L,
Stiehm ER, et al.
AIDS 2000 Jul 7;14(10):1389-99
Abstract |
| |
|
| |
FULL-TEXT ARTICLE
Lack of Long-term Effects of In Utero Exposure to Zidovudine Among Uninfected
Children
Born to HIV-Infected Women.
Culnane M, Fowler M, Lee SS,
et al.
JAMA 1999 Jan 13;281(2):151-7
Paper |
| |
|
| |
The Ariel Project: A Prospective Cohort Study of Maternal-Child Transmission of
Human
Immunodeficiency Virus Type 1 in the Era of Maternal Antiretroviral Therapy
Van Dyke RB, Korber BT, Popek E, et al.
J Infect Dis 1999 Feb;179(2):319-28
Abstract
|
Conference Reports,
Abstracts and Posters
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
|
|
New
and Noteworthy
Efficacy
Main
New/Newsworthy
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader